Please assess the completion status of the following clinical trial:

Trial Title: Intraosseous Infusion of Unrelated Cord Blood Grafts

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 36 months to 60 years old (YO)~2. No prior autologous or allogeneic transplant~3. Karnofsky performance score or Lansky Play-Performance of at least 80~Exclusion Criteria:~1. Age \< 36 months or \> 60 YO~2. creatinine clearance or nuclear medicine GFR of \< 50 mL/min~3. cardiac ejection fraction \< 50%~4. bilirubin \> 2 × upper limit of normal or ALT \> 4 × upper limit of normal or unresolved veno-occlusive disease~5. Pulmonary carbon monoxide diffusing capacity (DLCO), adjusted for Hgb \< 50%~6. Karnofsky performance score or Lansky Play-Performance Scale \<80~7. Uncontrolled viral, bacterial, or fungal infection at the time of study enrollment~8. Seropositive for HIV~9. Availability of a willing and well HLA matched related (genotypically identical or mismatched at a single allele or antigen defined by typing at HLA A, B, C and DRB1 loci) donor~10. Availability of a willing and well HLA matched unrelated (allele matched or mismatched at a single allele defined by allele level typing for HLA A, B, C and DRB1 loci) adult blood or marrow donor~11. Availability of an umbilical cord blood unit, which provides at least a 4/6 HLA match as defined above and ≥ 5.0 \* 107 NC/Kg (cryopreserved)

- Gender: ALL
- Minimum Age: 36 Months
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Receive two cord blood units. One administered by intraosseous infusion and the other by intravenous infusion. The second unit is being given as a safeguard, but will also allow the researchers to directly compare engraftment between intravenously and intraosseously infused cord blood units.

Based on this trial design, predict the completion outcome and termination type (if applicable).